cerrar
Tagged with US

US Generics: Company Culture Key to Attracting Talent
Two leading executives in the US generics market outline why robust company culture is key to attracting top talent that might otherwise gravitate…

South Africa Pharma News Roundup June 2020
Below is a roundup of latest news from South Africa's life sciences and healthcare industries, including a call to overhaul patent laws to allow…

CanSinoBIO: China’s Leading COVID-19 Vaccine Developer…
Chinese biotech CanSinoBIO is racing against the clock to have a COVID-19 vaccine ready to begin production in early 2021. The firm’s senior VP of…

The FDA’s COVID-19 Shakeup
In a recent virtual town hall meeting hosted by BIO, two key leaders from the US FDA laid out how their organisation has adjusted in the wake of the…

Korean Corestem Targets US Market for Ground-Breaking ALS…
After failing to attain reimbursement for its Amyotrophic Lateral Sclerosis (ALS) treatment NEURONATA-R® in Korea, Corestem has its sights set on the…

BIO 2020: How COVID-19 Will Radically Alter Global Biomedical…
The BIO International Convention was held digitally in June 2020, bringing together over 7,000 participants from around the world. In an…

Menarini Makes Big US Oncology Move with Stemline Acquisition
Menarini Group, the largest Italian pharmaceutical company by turnover, has made its first move into the US oncology market through the acquisition of…

2020: A Watershed Year for Chinese Biotech
2020 will certainly go down in history as a watershed year for the global community, as a new strain of coronavirus – later named SARS-CoV-19 –…

COVID-19: 95% of US Rare Disease Patients Affected
As of 11 June 2020, there have been over two million confirmed cases of COVID-19 in the US and over 115,000 deaths, with the US having occupied the…

COVID-19: Algeria Moves to Boost Foreign Direct Investment
In Algeria, the supplementary Finance Law for 2020 has just been published in the Official Gazette. This law materializes the authorities’ will to…

Peter L. Saltonstall – President & CEO, National…
Peter L Saltonstall, president and CEO of the US National Organization for Rare Disorders (NORD) shares the organization’s key priorities, what…

Five Cell & Gene Companies to Know in Europe
The cell and gene therapy market was valued at USD 6 billion in 2017 and is projected to exceed USD 35 billion in value by 2026. Moreover, these…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here